EXAS Stock Analysis: Buy, Sell, or Hold?
EXAS - Exact Sciences Corp
$104.91
0.99 (0.95%)
▲
5d:
+1.29%
30d:
+1.57%
90d:
+3.15%
BUY
MODERATE Confidence
Analysis Updated: Mar 20, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When EXAS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EXAS shows positive signals but monitor for confirmation. Market pricing in 11.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: EXAS shows positive signals but monitor for confirmation. Market pricing in 11.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$91.53
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$56.83
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EXAS is currently trading at $104.91, which is considered fair based on recent price action. From a valuation perspective, the stock is trading at a discount (Forward PE: 55.8) compared to its historical average (79.4). Remarkably, the market is currently pricing in an annual earnings decline of 11.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EXAS is in a strong downtrend. The price is currently testing key support at $103.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EXAS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EXAS is in a strong downtrend. The price is currently testing key support at $103.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EXAS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
65/100
(BUY)
Volume Confirmation
UNKNOWN
Confidence Score
73.8%
Protect Your Profits
EXAS is technically overbought (RSI 76). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- NEUTRAL: Near Wall St target ($105.81)
Support & Resistance Levels
Support Level
$103.22
Resistance Level
$104.98
Current Trend
Strong Downtrend
Technical data as of
Mar 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
55.80
Wall Street Target
$105.81
(+0.9%)
Revenue Growth (YoY)
23.1%
Profit Margin
-6.4%
Valuation Discount vs History
-11.1% cheaper
PE vs Historical
55.8 vs 79.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.1%
(market-implied from PE analysis)
1-Year Target
$94.42
(-10%)
2-Year Target
$84.98
(-19%)
3-Year Target
$76.48
(-27%)
3-Yr Target (if PE normalizes)
(PE: 56→79)
$108.82
(+4%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 55.8, Growth: 65.6%)
$354.07
(+238%)
Base:
(SPY PE: 22.4, Growth: 65.6%)
$142.00
(+35%)
Bear:
(PE: 19.0, Growth: 65.6%)
$120.70
(+15%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 55.8 to 79.4
Stabilization Target:
$149.27
(+42.3%)
PE Expansion Potential:
+42.3%
Share & Embed Analysis
Last updated: May 14, 2026 6:35 PM ET
Data refreshes hourly during market hours. Next update: 7:35 PM
Data refreshes hourly during market hours. Next update: 7:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EXAS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jacob A Orville
SELL
5000 shares
2025-11-19
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$620 | 55 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$250 | 58 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 58 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$229 | 60 BUY |
Advanced EXAS Option Strategies
Professional options setups generated by AI based on today's EXAS price and gamma walls.
